Manhattan Associates, Inc. earnings releases MANH

Manhattan Associates, Inc. last reported quarterly results on Jul 28, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): revenue of $297.8 million (+9.3% year over year) and diluted EPS of $0.85. It usually reports 21–28 days after a quarter ends. Based on that pattern, the next release is estimated for around Oct 20, 2026.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 21–28 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Jul 28, 2026
28 days after quarter end
Q2 FY2026
ended Jun 30, 2026
298
+9.3%
50
-11.3%
0.85
-8.6%
Apr 21, 2026
21 days after quarter end
Q1 FY2026
ended Mar 31, 2026
282
+7.4%
49
-6.3%
0.82
-3.5%
Jan 27, 2026
27 days after quarter end
Q4 FY2025
ended Dec 31, 2025
270
+5.7%
52
+8.2%
0.86
+10.9%
Oct 21, 2025
21 days after quarter end
Q3 FY2025
ended Sep 30, 2025
276
+3.4%
59
-8.1%
0.96
-6.8%
Jul 22, 2025
22 days after quarter end
Q2 FY2025
ended Jun 30, 2025
272
+2.7%
57
+7.6%
0.93
+9.4%
Apr 22, 2025
22 days after quarter end
Q1 FY2025
ended Mar 31, 2025
263
+3.2%
53
-2.3%
0.85
-1.2%
Jan 28, 2025
28 days after quarter end
Q4 FY2024
ended Dec 31, 2024
256
+7.4%
48
-1.5%
0.77
-0.3%
Oct 22, 2024
22 days after quarter end
—
ended Sep 30, 2024
—
—
—

Company profile

Industry
Services-Prepackaged Software (SIC 7372)
Listed as
MANH (Nasdaq)
Fiscal year ends
December 31
Incorporated in
GA
Headquarters
Atlanta, GA
SEC filer status
Large accelerated filer
SEC CIK
1056696

Other Services-Prepackaged Software companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.